AED Aedifica NV/SA

69.87USD63.70 EUR · EBR-2.38%Mkt Cap: 5.83B USDP/E: 6.34

Aedifica NV/SA is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. Aedifica has built a real estate portfolio worth approximately 1…

Institutional holders10 on file

Key Statistics

Company
Market Cap5.83B USD
Enterprise Value12.71B USD
Revenue (TTM)532.39M USD
Gross Profit382.30M USD
Net Income (TTM)268.10M USD
Revenue/Share9.06 USD
Last Price69.87 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees127
CountryBE
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINBE0003851681
Valuation
P/E (Trailing)6.34
P/E (Forward)11.51
PEG—
EV/EBITDA28.73
EV/Revenue23.87
P/S10.95
P/B0.83
EPS (TTM)11.01 USD
EPS (Forward)6.09 USD
52W Range
66.1917% of range87.80
52W High87.80 USD
52W Low66.19 USD
Profitability
Gross Margin94.16%
Oper. Margin82.71%
EBITDA Margin83.07%
Profit Margin66.03%
ROE6.67%
ROA3.77%
ROIC4.34%
ROCE5.33%
Growth
Revenue Growth104.30%
Earnings Growth-12.70%
Cash Flow & Leverage
Operating CF348.61M USD
CapEx (TTM)106.89M USD
FCF Margin61.66%
FCF Yield5.63%
Net Debt5.86B USD
Net Debt/EBITDA13.24
Net Debt/FCF17.84
Balance Sheet
Debt/Equity0.70
Current Ratio0.13
Quick Ratio0.08
Book Value/Sh84.31 USD
Cash/Share0.73 USD
Dividends
Fwd Div Rate4.39 USD
Trail. Div Rate4.39 USD
Div. Yield6.13%
5Y Avg Yield4.21%
Payout Ratio39.84%
Ex-Div DateMay 14, 2026
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)87.62 USD
Upside (mean)+25.4%
Target Range73.49 USD – 95.42 USD
73.49+25.4% to mean95.42
# Analysts9
Ownership
Shares Out.83.47M
Float83.42M
Insiders0.06%
Institutions39.33%
Technical
SMA 5070.33 (-0.7%)
SMA 20076.08 (-8.2%)
Beta0.96
S&P 52W Chg12.08%
Avg Vol (30d)120.38K
Avg Vol (10d)109.92K
Technical Indicators
RSI (14)42.0
MACD0.4140
MACD Signal0.4677
MACD Hist.-0.0537
BB Upper73.50 USD
BB Middle70.96 USD
BB Lower68.42 USD
BB Width7.16%
ATR (14)1.115 USD
Vol Ratio (20d)1.77x

About Aedifica (EBR: AED)

›

Aedifica (EBR: AED) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the REIT - Healthcare Facilities industry, part of the Real Estate sector, and reports about 127 employees.

The shares were at 63.70 EUR on 19 November 2026, down 4.1% over 52 weeks. Its 52-week range is 60.35 EUR to 80.05 EUR: the price is 20.4% below the high and 5.6% above the low.

At a market capitalisation of 5.32B EUR, it trades at 6.3 times trailing earnings and 11.5 times forward earnings. The median trailing P/E of its 15 largest REIT - Healthcare Facilities peers is 25.6, a discount of 75% for AED. It pays a dividend yielding 6.13% (it pays out 40% of its earnings), against a median of 5.65% among the dividend payers in that peer group.

Aedifica reports return on equity of 6.7%, an operating margin of 82.7% and revenue up 104.3% year over year.

Its debt exceeds its cash by 5.34B EUR, a debt-to-equity ratio of 0.70. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 9 analysts cover the stock, with an average rating of Buy; their mean price target of 79.89 EUR is 25.4% above the current price. The next earnings report is expected on 17 February 2027.